Othus, M., Garcia-Manero, G., Appelbaum, F. R., Erba, H. P., Dietrich, E., Raychaudhuri, S., … Percival, M.-E. (2025). Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203. Leukemia, 39(3), 752–754. https://doi.org/10.1038/s41375-024-02512-3

Othus, Megan, Guillermo Garcia-Manero, Frederick R. Appelbaum, Harry P. Erba, Eliana Dietrich, Suravi Raychaudhuri, Jacob Appelbaum, Elihu Estey, and Mary-Elizabeth Percival. “Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203.” Leukemia 39, no. 3 (March 2025): 752–54. https://doi.org/10.1038/s41375-024-02512-3.

Othus M, Garcia-Manero G, Appelbaum FR, Erba HP, Dietrich E, Raychaudhuri S, et al. Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203. Leukemia. 2025 Mar;39(3):752–4.

Othus, Megan, et al. “Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203.” Leukemia, vol. 39, no. 3, Mar. 2025, pp. 752–54. Pubmed, doi:10.1038/s41375-024-02512-3.

Othus M, Garcia-Manero G, Appelbaum FR, Erba HP, Dietrich E, Raychaudhuri S, Appelbaum J, Estey E, Percival M-E. Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203. Leukemia. 2025 Mar;39(3):752–754.